Search
Summit Therapeutics Inc
SMMTAdd to Watchlist
13.105USD
-0.555-4.06%
Close 07-27 16:00（ET）Quotes delayed by 15 min
10.39BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-27The current institutional shareholding score of Summit Therapeutics Inc is 3.00, ranking 192 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 15.81%, representing a quarter-over-quarter increase of 11.68%. The largest institutional shareholder is Steven Cohen, holding a total of 856.57K shares, representing 0.10% of shares outstanding, with 0.99% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
Duggan (Robert William)
Baker Bros. Advisors LP
Zanganeh (Mahkam)
Xia (Yu)
Fidelity Management & Research Company LLC
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
1
2